TickerGuard
Buy Day today: Poor (42) Weak market breadth · no major macro event
MDXG

MiMedx Group Inc

Healthcare · Biotechnology

3.10$ +0.0% vs. previous close Closing price · As of: Nov 20, 2026

Investor relations

Report Dates

Investor relations overview for MiMedx Group Inc (MDXG): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 10/28/2026.

Next report 10/28/2026
Last report 10/28/2026
Earnings surprise by quarter (%)
Q4 23 · 357.1 % 23 Q1 24 · 75.0 % 24 Q2 24 · 0.0 % 24 Q3 24 · 40.0 % 24 Q4 24 · -6.7 % 24 Q1 25 · -16.7 % 25 Q2 25 · 66.7 % 25 Q3 25 · 87.5 % 25 Q4 25 · 50.7 % 25 Q1 26 · -25.0 % 26 Q2 26 · -66.7 % 26

EPS estimate beaten

Full history 22 of 52 quarters (42%)
Last 16 quarters 10 of 16 quarters (63%)

Earnings Call Transcripts

Search all transcripts →

  • 10/28/2026 Earnings Call Q3 2026 Open →
  • 07/29/2026 Earnings Call Q2 2026 Open →
  • 02/26/2026 Earnings Call Q4 2025 Open →
  • 10/29/2025 Earnings Call Q3 2025 Open →
  • 07/30/2025 Earnings Call Q2 2025 Open →
  • 04/30/2025 Earnings Call Q1 2025 Open →
  • 02/26/2025 Earnings Call Q4 2024 Open →
  • 10/30/2024 Earnings Call Q3 2024 Open →
  • 07/31/2024 Earnings Call Q2 2024 Open →
  • 04/30/2024 Earnings Call Q1 2024 Open →

News on This Stock

  • 10/28/2026 MIMEDX GROUP, INC. (MDXG): Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Exhibits · sec.gov Open ↗
  • 10/16/2026 MIMEDX GROUP, INC. (MDXG): Other Events · sec.gov Open ↗
  • 07/29/2026 MIMEDX GROUP, INC. (MDXG): Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Exhibits · sec.gov Open ↗
  • 07/29/2026 MIMEDX GROUP, INC. (MDXG): Entry into a Material Definitive Agreement; Regulation FD Disclosure; Financial Statements and Exhibits · sec.gov Open ↗

Automatically matched wire and portal stories; external links open the original source.

Data as of: November 20, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?